|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics. CA Cancer J Clin.
58:71–96. 2008.
|
|
2
|
She Ben: Annual Report On Health and
Population Health Status of Beijing 2011 (Chinese Edition).
People’s Health Publishing House; Beijing, China: 2012, (In
Chinese).
|
|
3
|
Thamilselvan V, Menon M and Thamilselvan
S: Carmustine enhances the anticancer activity of selenite in
androgen-independent prostate cancer cells. Cancer Manag Res.
4:383–395. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Williams TM, Hassan GS, Li J, et al:
Caveolin-1 promotes tumor progression in an autochthonous mouse
model of prostate cancer: genetic ablation of Cav-1 delays advanced
prostate tumor development in tramp mice. J Biol Chem.
280:25134–25145. 2005. View Article : Google Scholar
|
|
5
|
Williams TM and Lisanti MP: Caveolin-1 in
oncogenic transformation, cancer, and metastasis. Am J Physiol Cell
Physiol. 288:C494–C506. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Toepfer N, Childress C, Parikh A,
Rukstalis D and Yang W: Atorvastatin induces autophagy in prostate
cancer PC3 cells through activation of LC3 transcription. Cancer
Biol Ther. 12:691–699. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bansal D, Undela K, D’Cruz S and Schifano
F: Statin use and risk of prostate cancer: a meta-analysis of
observational studies. PLoS One. 7:1–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang CC, Ho SC, Chiu HF and Yang CY:
Statins increase the risk of prostate cancer: a population-based
case-control study. Prostate. 71:1818–1824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murtola TJ, Syvälä H, Pennanen P, Bläuer
M, Solakivi T, Ylikomi T and Tammela TL: Comparative effects of
high and low-dose simvastatin on prostate epithelial cells: the
role of LDL. Eur J Pharmacol. 673:96–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rosenthal I, Sostaric JZ and Riesz P:
Sonodynamic therapy - a review of the synergistic effects of drugs
and ultrasound. Ultrason Sonochem. 11:349–363. 2004.PubMed/NCBI
|
|
11
|
Ashush H, Rozenszajn LA, Blass M, et al:
Apoptosis induction of human myeloid leukemic cells by ultrasound
exposure. Cancer Res. 60:1014–1020. 2000.PubMed/NCBI
|
|
12
|
Korosoglou G, Hardt SE, Bekeredjian R, et
al: Ultrasound exposure can increase the membrane permeability of
human neutrophil granulocytes containing microbubbles without
causing complete cell destruction. Ultrasound Med Biol. 32:297–303.
2006. View Article : Google Scholar
|
|
13
|
Korosoglou G, Behrens S, Bekeredjian R, et
al: The potential of a new stable ultrasound contrast agent for
site-specific targeting. An in vitro experiment. Ultrasound Med
Biol. 32:1473–1478. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Ren CH, Tahir SA, Ren C and Thompson
TC: Caveolin-1 maintains activated Akt in prostate cancer cells
through scaffolding domain binding site interactions with and
inhibition of serine/threonine protein phosphatases PP1 and PP2A.
Mol Cell Biol. 23:9389–9404. 2003. View Article : Google Scholar
|
|
15
|
Kochuparambil ST, Al-Husein B, Goc A,
Soliman S and Somanath PR: Anticancer efficacy of simvastatin on
prostate cancer cells and tumor xenografts is associated with
inhibition of Akt and reduced prostate-specific antigen expression.
J Pharmacol Exp Ther. 336:496–505. 2011. View Article : Google Scholar
|
|
16
|
Zhang Z, Chen J, Chen L, et al: Low
frequency and intensity ultrasound induces apoptosis of brain
glioma in rats mediated by caspase-3, Bcl-2, and survivin. Brain
Res. 1473:25–34. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng Y, Tian Z and Wan M: Bioeffects of
low-intensity ultrasound in vitro: apoptosis, protein profile
alteration, and potential molecular mechanism. J Ultrasound Med.
29:963–974. 2010.PubMed/NCBI
|
|
18
|
Spampanato C, De Maria S, Sarnataro M, et
al: Simvastatin inhibits cancer cell growth by inducing apoptosis
correlated to activation of Bax and down-regulation of BCL-2 gene
expression. Int J Oncol. 40:935–941. 2012.PubMed/NCBI
|
|
19
|
Kamigaki M, Sasaki T, Serikawa M, et al:
Statins induce apoptosis and inhibit proliferation in
cholangiocarcinoma cells. Int J Oncol. 39:561–568. 2011.PubMed/NCBI
|
|
20
|
Relja B, Meder F, Wilhelm K, Henrich D,
Marzi I and Lehnert M: Simvastatin inhibits cell growth and induces
apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells. Int
J Mol Med. 26:735–741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shaul PW and Anderson RG: Role of
plasmalemmal caveolae in signal transduction. Am J Physiol.
275:L843–L851. 1998.PubMed/NCBI
|
|
22
|
Wiechen K, Diatchenko L, Agoulnik A, et
al: Caveolin-1 is down-regulated in human ovarian carcinoma and
acts as a candidate tumor suppressor gene. Am J Pathol.
159:1635–1643. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Racine C, Bélanger M, Hirabayashi H,
Boucher M, Chakir J and Couet J: Reduction of caveolin 1 gene
expression in lung carcinoma cell lines. Biochem Biophys Res
Commun. 255:580–586. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sloan EK, Stanley KL and Anderson RL:
Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene.
23:7893–7897. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang G, Truong LD, Timme TL, et al:
Elevated expression of caveolin is associated with prostate and
breast cancer. Clin Cancer Res. 4:1873–1880. 1998.PubMed/NCBI
|
|
26
|
Thompson TC, Tahir SA, Li L, et al: The
role of caveolin-1 in prostate cancer: clinical implications.
Prostate Cancer Prostatic Dis. 13:6–11. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iguchi K, Matsunaga S, Nakano T, Usui S
and Hirano K: Inhibition of caveolin-1 expression by incadronate in
PC-3 prostate cells. Anticancer Res. 26:2977–2982. 2006.PubMed/NCBI
|
|
28
|
Schlicher RK, Radhakrishna H, Tolentino
TP, Apkarian RP, Zarnitsyn V and Prausnitz MR: Mechanism of
intracellular delivery by acoustic cavitation. Ultrasound Med Biol.
32:915–924. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meijering BD, Juffermans LJ, van Wamel A,
et al: Ultrasound and microbubble-targeted delivery of
macromolecules is regulated by induction of endocytosis and pore
formation. Circ Res. 104:679–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zundel W, Swiersz LM and Giaccia A:
Caveolin 1-mediated regulation of receptor tyrosine
kinase-associated phosphatidylinositol 3-kinase activity by
ceramide. Mol Cell Biol. 20:1507–1514. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li L, Ittmann MM, Ayala G, et al: The
emerging role of the PI3-K-Akt pathway in prostate cancer
progression. Prostate Cancer Prostatic Dis. 8:108–118. 2005.
View Article : Google Scholar : PubMed/NCBI
|
